Krista Fogarty - 22 Dec 2022 Form 4 Insider Report for Lipocine Inc. (LPCN)

Role
Principal Accounting Officer
Signature
/s/ Krista Fogarty
Issuer symbol
LPCN
Transactions as of
22 Dec 2022
Net transactions value
+$37,658
Form type
4
Filing time
22 Dec 2022, 18:18:05 UTC
Previous filing
17 May 2022
Next filing
12 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LPCN Stock Option (Right to Buy) Award $37,658 +91,850 +67% $0.4100 229,850 22 Dec 2022 Common Stock 91,850 $0.4100 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 22, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years.